TTrialPathMatch Me to Trials
← Back to trials
RecruitingSubchondral Cyst

Knee Related Subchondral Bone Lesions Treated With IOBP

Eligible age

18–60 yrs

Accepts

All genders

Locations

5 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing system to treat subchondral bone pathology (SBP).

Sponsor: Arthrex, Inc.

You may qualify if…

  • ✓ 1. Able to read, understand, sign and complete informed consent
  • ✓ 2. Male or female subject between the ages of 18-60 years
  • ✓ 3. Subject has had pain for greater than three months
  • ✓ 4. Subjects with single SBP in tibia or femur confirmed by minimum 1.5T MRI (including coronal, axial, sagittal, lateral femur, and lateral tibia views) and are candidates for an IOBP® procedure
  • ✓ 5. Subject has stable ligaments
  • ✓ 6. Subject has neutral alignment (max 5° varus or valgus)
  • ✓ 7. Subject has a VAS score greater than or equal to five
  • ✓ 8. Subject is scheduled to undergo surgical intervention using IOBP®

You may not qualify if…

  • ✕ 1. Subject has diabetes Type I, Type II uncontrolled, or Type II insulin dependent
  • ✕ 2. Subject has had lower extremity surgery within six months
  • ✕ 3. Subject has had more than two prior surgical procedures in the operative leg
  • ✕ 4. Subject has a neuromuscular condition
  • ✕ 5. Subject has a current infection
  • ✕ 6. Subject has a BMI \>35
  • ✕ 7. Subject has subchondral bone collapse or Kellgren Lawrence grade IV osteoarthritis
  • ✕ 8. Subject has joint surface collapse in late stage avascular necrosis

Where it's recruiting

Colorado

Denver

Florida

Gulf Breeze

Maryland

Salisbury

Ohio

Columbus

Pennsylvania

Pittsburgh

Source: ClinicalTrials.gov · NCT05314608 · last updated 2022-12-05